Ischemia Modified Albumin: A New Serum Marker For...
Ischemia Modified Albumin: A New Serum Marker for Myocardial Ischemia (9877-08)
Explore the development of ischemia modified albumin test (the albumin cobalt binding test), its use and limitations. This test is able to measure cardiac muscle ischemia prior to necrosis.
| Code |
9877-08 |
| Niveau |
Fondamental |
Prix membres
$0
Prix non-membres
$135
Renseignements additionnels
PEP hours: 10
CPS/ART credits: 0
Learning Outcomes:
- Define the term ischemic heart disease.
- Draw the major anatomic details of the heart.
- Briefly describe the four major types of cardiac syndromes.
- Describe the principle of the albumin cobalt binding test as a means of detection of ischemic modified albumin.
- Give an overview of the status of laboratory cardiac marker tests.
- Discuss the limitations of the albumin cobalt binding test as a method for detection of early cardiac ischemia.
- List the approximate sensitivity, specificity, positive and negative predictive values of the albumin cobalt binding test and its interpretation.
- Discuss the possible clinical use for the albumin cobalt binding test.
Instructor: John Chapman, FCSMLS, FIMLS, CLSp(H)
Prerequisites: None
Textbook: N/A
Equipment: Computer with Internet is required
Start Date: Upon registration
Completion: Up to 52 weeks
Version Date: October 2008